Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer

J.M. Rademaker-Lakhai; S. Horenblas; W. Meinhardt; E. Stokvis; T.M. de Reijke; J.M. Jimeno; L. Lopez-Lazaro; J.A.L. Martin; J.H. Beijnen; J.H.M. Schellens

Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer

J.M. Rademaker-Lakhai
, S. Horenblas
, W. Meinhardt
, E. Stokvis
, T.M. de Reijke
, J.M. Jimeno
, L. Lopez-Lazaro
, J.A.L. Martin
, J.H. Beijnen
, J.H.M. Schellens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1854-1862
Number of pages	9
Journal	Clinical Cancer Research
Volume	11
Issue number	5
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{31220fc788cc4837bdb6600f131900bb,

title = "Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer",

author = "J.M. Rademaker-Lakhai and S. Horenblas and W. Meinhardt and E. Stokvis and \{de Reijke\}, T.M. and J.M. Jimeno and L. Lopez-Lazaro and J.A.L. Martin and J.H. Beijnen and J.H.M. Schellens",

year = "2005",

language = "Undefined/Unknown",

volume = "11",

pages = "1854--1862",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer

AU - Rademaker-Lakhai, J.M.

AU - Horenblas, S.

AU - Meinhardt, W.

AU - Stokvis, E.

AU - de Reijke, T.M.

AU - Jimeno, J.M.

AU - Lopez-Lazaro, L.

AU - Martin, J.A.L.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1078-0432

VL - 11

SP - 1854

EP - 1862

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 5

ER -